4Kato H, Igaki H, Tachimori Y, et al. Assessment of cervical lymph node metastasis in the staging of thoracic esophageal carcinoma[J]. J Surg Oncol, 2000, 7,1(4):282- 285. 被引量：1
3Hsu CP, Chen CY, Hsia JY, et al. Prediction of prognosis by the extent of lymph node involvement in squamous cell carcinoma of the tboracic esophagus. Eur J Cardiothorac Surg, 2001, 19(1): 10-13. 被引量：1
4Kunisaki C, Akiyama H, Nomura M, et al. Developing an appropriate staging system for esophageal carcinoma. J Am Coll Surg, 2005, 201(6):884-890. 被引量：1
6Rizk N, Venkatraman E, Park B, et al. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardinvase Surg, 2006, 132(6): 1374-1381. 被引量：1
7Wilson M. Rosato EL, Chojnacki KA, et al. Prognostic significance of lymph node metastases and ratio in esophageal cancer. J Surg Res, 2008, 146(1): 11-15. 被引量：1
8Mariette C, Piessen G, Briez N, et al. The number ofmelastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal regardless of lymphadenectomy extent. neoadjuvant chemoradiation or Ann Surg, 2008, 247(2): 365-371. 被引量：1
9Hosch SB, Stoecklein NH, Pichlmeier U, et al. Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. J Clin Oncol, 2001, 19(7): 1970-1975. 被引量：1
10Shimada H, Okazumi S, Matsubara H, et al. Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three field lymph node dissection. World J Surg, 2006, 30(8): 1441-1449. 被引量：1
7Riikka Mattila,Kalle Alanen,Stina Syrj?nen.Immunohistochemical study on topoisomerase IIα, Ki-67 and cytokeratin-19 in oral lichen planus lesions[J]. Archives of Dermatological Research . 2007 (8) 被引量：1
8Shi H,Lu D,Shu Y,et al.Expression of multidrug resistance-related proteins P-glycoproteinglu-tathione-s-transferases,ToPoisomerase-Ⅱand lung resistance protein in primary gastric cardiac adeno-carcinoma. Cancer Investigation . 2008 被引量：1
9Homs MY,van der Gaast A,Siersema PDet al.WITHDRAWN:Chemotherapy for metastatic carci-noma of the esophagus and gastro-esophageal junction. Cochrane Database of Systematic Reviews . 2010 被引量：1
10Chikamori K,Grozav AG,Kozuki Tet al.DNA topoisomeraseⅡenzymes as molecular targets for cancer chemotherapy. Current Cancer Drug Targets . 2010 被引量：1
